-- French drugmaker Sanofi SA (SNY) plans to appoint Paul Hudson, a top executive with Switzerland's Novartis, to become its next chief executive, Reuters reported Thursday, citing a source familiar with the decision.

-- Current Sanofi CEO Olivier Brandicourt will leave the company to retire, the report said.

-- Hudson was chosen because of his reputation and is known as a solid manager and has an expertise in digital relating to pharmaceuticals, the report said.

Write to Patrick Thomas at patrick.thomas@wsj.com

(END) Dow Jones Newswires

June 06, 2019 18:57 ET (22:57 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Sanofi
Sanofi (NASDAQ:SNY)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Sanofi